Nurix Therapeutics (NRIX) Leases (2021 - 2025)
Historic Leases for Nurix Therapeutics (NRIX) over the last 5 years, with Q4 2025 value amounting to $50.5 million.
- Nurix Therapeutics' Leases rose 7952.66% to $50.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was $50.5 million, marking a year-over-year increase of 7952.66%. This contributed to the annual value of $50.5 million for FY2025, which is 7952.66% up from last year.
- As of Q4 2025, Nurix Therapeutics' Leases stood at $50.5 million, which was up 7952.66% from $53.0 million recorded in Q3 2025.
- In the past 5 years, Nurix Therapeutics' Leases registered a high of $53.0 million during Q3 2025, and its lowest value of $5.8 million during Q2 2025.
- Over the past 5 years, Nurix Therapeutics' median Leases value was $15.9 million (recorded in 2022), while the average stood at $22.4 million.
- Its Leases has fluctuated over the past 5 years, first soared by 20002.22% in 2024, then plummeted by 7988.56% in 2025.
- Nurix Therapeutics' Leases (Quarter) stood at $14.0 million in 2021, then fell by 11.85% to $12.3 million in 2022, then skyrocketed by 152.26% to $31.1 million in 2023, then dropped by 9.64% to $28.1 million in 2024, then skyrocketed by 79.53% to $50.5 million in 2025.
- Its Leases stands at $50.5 million for Q4 2025, versus $53.0 million for Q3 2025 and $5.8 million for Q2 2025.